Areas of Focus
- Epigenetic transcriptional regulation and tumor metastasis
Work Experience
- 2017-2023 Associate Professor, Department of Cell and Genetics, Shenyang Medical College
- 2023-present Associate Professor, Basic Medical College, Chongqing Medical University
Academic Background & Achievements
- 2005-2009 Bachelor in Biotechnology: Jilin University
- 2009-2012 Master in Biochemistry and Molecular Biology: Jilin University
- 2012-2017 PhD in Tumor Epigenetics: University of Göttingen
- Hosted a National Natural Science Foundation project
Publications
- PHF13 epigenetically activates TGFbeta driven epithelial to mesenchymal transition, Sun Y, Li D, Liu H, Huang Y, Meng F, Tang J, Li Z, Xie W, 2022
- The H2B ubiquitin-protein ligase RNF40 is required for somatic cell reprogramming, Xie W, Miehe M, Laufer S, Johnsen SA, 2020
- CRISPR Start-Loss: A Novel and Practical Alternative for Gene Silencing through Base-Editing-Induced Start Codon Mutations, Chen S, Xie W, Liu Z, Shan H, Chen M, Song Y, Yu H, Lai L, Li Z, 2020
- RNF40 regulates gene expression in an epigenetic context-dependent manner, Xie W, Nagarajan S, Baumgart SJ, Kosinsky RL, Najafova Z, Kari V, Hennion M, Indenbirken D, Bonn S, Grundhoff A, Wegwitz F, Mansouri A, Johnsen SA, 2017